Gene Correction of Wiskott–Aldrich syndrome iPS Cells Rescues Proplatelet Defects and Improves Platelet Size
Thrombosis and Haemostasis · 01.11.2025 · 125 (11) · 1115-1126
DOI: 10.1055/a-2508-0983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.11.2025. Verfasst von Praewphan Ingrungruanglert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence for Stem Cell and Cell Therapy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Wiskott-Aldrich Syndrome, Induced Pluripotent Stem Cells, Wiskott-Aldrich Syndrome Protein, Blood Platelets. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Wiskott–Aldrich syndrome (WAS) is a severe X-linked disorder caused by loss-of-function mutations in the WAS gene, responsible for encoding WAS protein (WASP), a key regulator of the actin cytoskeleton in all hematopoietic cells, except red blood cells. The mechanism underlying microthrombocytopenia, a distinctive feature of WAS and a major contributor to mortality, remains not fully elucidated. In this study, using different gene-editing strategies, we corrected mutations in patient-derived WAS-induced pluripotent stem cell (iPSC) lines, generating isogeneic WAS-iPSC lines. These included lines with direct mutation-specific correction and lines incorporating a WASP transgene cassette regulated by the MND or WAS1.6 kb promoter integrated at the safe harbor AAV1 site. Our results demonstrated that direct mutation correction successfully restored WASP levels to the equivalent of the wild-type in iPSC-derived megakaryocytes (MKs). In contrast, the AAV1-targeted strategy using the MND and WAS1.6 promoters yielded a lower level of WASP. Notably, only the mutation-specific correction lines exhibited improvements in proplatelet structures and generated larger-sized platelets. Our findings underscore the crucial roles of WASP during human thrombopoiesis and suggest that therapeutic approaches, such as direct gene correction, which can achieve physiologic levels of WASP in MKs, hold promise for ameliorating platelet defects in individuals with WAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Excellence for Stem Cell and Cell Therapy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Excellence Center for Stem Cell and Cell Therapy, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
- Department of Pediatrics, Faculty of Medicine, Center of Excellence for Medical Genomics, Medical Genomics Cluster, Chulalongkorn University, Bangkok, Thailand.
- Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
- Department of Basic Medical Science, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
- Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Faculty of Medicine, Center of Excellence for Allergy and Clinical Immunology, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Nipan Israsena
Zitieren
APA
Ingrungruanglert, P., Phodang, S., Amarinthnukrowh, P., Meehart, P., Pratedrat, P., Suratannon, N., Shotelersuk, V., Suphapeetiporn, K., & Israsena, N. (2025). Gene Correction of Wiskott–Aldrich syndrome iPS Cells Rescues Proplatelet Defects and Improves Platelet Size. Thrombosis and Haemostasis, 125(11), 1115-1126. https://doi.org/10.1055/a-2508-0983
Vancouver
Ingrungruanglert P, Phodang S, Amarinthnukrowh P, Meehart P, Pratedrat P, Suratannon N, et al. Gene Correction of Wiskott–Aldrich syndrome iPS Cells Rescues Proplatelet Defects and Improves Platelet Size. Thrombosis and Haemostasis. 2025;125(11):1115-1126. doi:10.1055/a-2508-0983
BibTeX
@article{Ingrungruanglert2025,
author = {Ingrungruanglert, Praewphan and Phodang, Sarinya and Amarinthnukrowh, Pramuk and Meehart, Phattarawan and Pratedrat, Pornpitra and Suratannon, Narissara and Shotelersuk, Vorasuk and Suphapeetiporn, Kanya and Israsena, Nipan},
title = {Gene Correction of Wiskott–Aldrich syndrome iPS Cells Rescues Proplatelet Defects and Improves Platelet Size},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {11},
pages = {1115--1126},
doi = {10.1055/a-2508-0983}
}
EUVIMED